FDA Adverse Event Injury Summary report: N

RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM

MDR report key: 11113613 · Received January 4, 2021

Report

Report Number
2247858-2021-00004
Event Type
Injury
Date Received
January 4, 2021
Date of Event
November 10, 2020
Report Date
March 23, 2021
Manufacturer
BOLTON MEDICAL, INC.
Product Code
MIH
PMA / PMN Number
P110038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

BOLTON MEDICAL IS VOLUNTARILY REPORTING A DEVICE MALFUNCTION RELATED TO THE RELAYNBS PLUS THORACIC STENT-GRAFT SYSTEM. THE RELAYNBS PLUS DEVICE IS NOT MARKETED IN THE US, HOWEVER IT IS SIMILAR TO THE RELAY THORACIC STENT GRAFT WITH PLUS DELIVERY SYSTEM APPROVED FOR SALE IN THE US IN 2012 (P110038). THE RELAYNBS PLUS RELATED EVENT OCCURED IN GERMANY.

Description of Event or Problem · 0

ENDOLEAK TYPE IA WE HAVE A NOTE THAT SURGEON DESCRIBED AE AS UNKNOWN CAUSE (UNDETERMINED). PATIENT WILL GET A NEW ANGIOGRAPHY AROUND 6 TILL 8 WEEKS. THEREFORE, WE HAVE TO ACCEPT UNKNOWN CAUSE AT THIS TIME. PATIENT OUTCOME - "PATIENT IS IN A GOOD CONDITION."

Additional Manufacturer Narrative · 1

BOLTON MEDICAL IS VOLUNTARILY REPORTING A DEVICE MALFUNCTION RELATED TO THE RELAYNBS PLUS THORACIC STENT-GRAFT SYSTEM. THE RELAYNBS PLUS DEVICE IS NOT MARKETED IN THE US, HOWEVER IT IS SIMILAR TO THE RELAY THORACIC STENT GRAFT WITH PLUS DELIVERY SYSTEM APPROVED FOR SALE IN THE US IN 2012 (P110038). THE RELAYNBS PLUS RELATED EVENT OCCURED IN (B)(6).

Description of Event or Problem · 1

ENDOLEAK TYPE IA. WE HAVE A NOTE THAT SURGEON DESCRIBED AE AS UNKNOWN CAUSE (UNDETERMINED). PATIENT WILL GET A NEW ANGIOGRAPHY AROUND 6 TILL 8 WEEKS. THEREFORE, WE HAVE TO ACCEPT UNKNOWN CAUSE AT THIS TIME. PATIENT OUTCOME - "ONGOING."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
3296 RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM STENT, ENDOVASCULAR GRAFT, AORTIC MIH BOLTON MEDICAL, INC. B180510204

Patients

Seq Age Sex Outcome Treatment
1 0 YR Other